Redefining Success in Cancer Care: A Meaningful‐Life–Centred Framework for Precision Medicine
Journal of Evaluation in Clinical Practice · 2026-12 · 32 (8)
DOI: 10.1111/jep.70734 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Evaluation in Clinical Practice, online erschienen am 09.11.2026. Verfasst von Takehiro Okabayashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi City, Kochi, Japan. Hauptthemen laut MEDLINE: Precision Medicine, Patient-Centered Care, Neoplasms, Medical Oncology. Die Arbeit nennt 36 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Precision medicine has revolutionized cancer care by tailoring therapies to distinct tumour characteristics; however, therapeutic success is still predominantly evaluated through objective tumour response and survival endpoints that fail to capture the complete lived experience of patients. Here, we propose Meaningful‐Life–Centred Precision Oncology (MLCPO), a novel conceptual framework that integrates tumour biology with host physiology, functional reserve, individual priorities, psychosocial context and dynamic longitudinal reassessment across the entire cancer continuum. Rather than replacing established paradigms—such as shared decision‐making, patient‐reported outcomes, survivorship care and patient‐centred research—MLCPO synthesizes these elements into an adaptive, single‐decision architecture designed to help individuals live according to their personal values. We contextualize MLCPO alongside contemporary initiatives, including Common Sense Oncology and existing survivorship frameworks, and detail its practical implications for clinician education, clinical workflows, research design and health policy. Successful implementation demands moving beyond abstract calls for person‐centred care towards seamless workflow integration, objective quality metrics, authentic patient partnership, aligned financial incentives and strict system accountability for patient‐relevant outcomes. As a conceptual model, MLCPO requires multi‐stakeholder co‐design, operational specification and prospective clinical evaluation before its definitive effectiveness can be established.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Kochi Health Sciences Center, Kochi City, Kochi, Japan.
- Kochi Health Sciences Center, Kochi City, Kochi, Japan.
- Department of Healthcare Quality and Management, Kochi Health Sciences Center, Kochi City, Kochi, Japan.
ORCID-Profile: Takehiro Okabayashi, Ryo Inada
Zitieren
APA
Okabayashi, T., Inada, R., Imai, T., Ozaki, K., & Hayashi, K. (2026). Redefining Success in Cancer Care: A Meaningful‐Life–Centred Framework for Precision Medicine. Journal of Evaluation in Clinical Practice, 32(8). https://doi.org/10.1111/jep.70734
Vancouver
Okabayashi T, Inada R, Imai T, Ozaki K, Hayashi K. Redefining Success in Cancer Care: A Meaningful‐Life–Centred Framework for Precision Medicine. Journal of Evaluation in Clinical Practice. 2026;32(8). doi:10.1111/jep.70734
BibTeX
@article{Okabayashi2026,
author = {Okabayashi, Takehiro and Inada, Ryo and Imai, Toshi and Ozaki, Kazuhide and Hayashi, Kazutoshi},
title = {Redefining Success in Cancer Care: A Meaningful‐Life–Centred Framework for Precision Medicine},
journal = {Journal of Evaluation in Clinical Practice},
year = {2026},
volume = {32},
number = {8},
doi = {10.1111/jep.70734}
}
EUVIMED